Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate Cancer

15 Nov 2018

Abstract excerpt

Rates of progression and treatment response in advanced prostate cancer are highly variable, necessitating non-invasive methods to assess the molecular characteristics of these tumors in real time. The unique potential of circulating tumor cells (CTCs) to serve as a clinically useful liquid biomarker is due to their ability to inform via both enumeration and RNA expression. A microfluidic graphene oxide-based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Prostate Cancer Treatment and Research
Share to Radiopharmaceutical Chemistry and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30693182
DOI: 10.1002/advs.201801254

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate CancerPMID 30693182Read ↗

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.Semantic proximity Read ↗

High throughput, label-free isolation of circulating tumor cell clusters in meshed microwellsSemantic proximity Read ↗

High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.Semantic proximity Read ↗

RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patientsSemantic proximity Read ↗

Unearthing a Prostate Cancer cfDNA Signature that "Stems" from AR Alterations.Semantic proximity Read ↗

Detection and phenotyping of circulating tumor cells in high-risk localized prostate cancer.Semantic proximity Read ↗

Precise Detection and Transcriptomic Concordant Analysis of Circulating Tumor Cells from Prostate CancerSemantic proximity Read ↗

Challenging the Current Paradigm of Liquid Biopsy Through Dielectrophoresis (DEP) In Prostate CancerSemantic proximity Read ↗

Molecular classification of prostate cancer using curated expression signaturesSemantic proximity Read ↗

Development and clinical validation of a microfluidic-based platform for CTC enrichment and downstream molecular analysisSemantic proximity Read ↗

A programmable multi-stage microfluidic platform with micro-dam prefiltration and micro-nano hierarchical filter for synergetic capture of CTCs and SERS-based phenotype analysis.Semantic proximity Read ↗

Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.